Publications by authors named "Malwina Smorczewska"
Article Synopsis
- Primary mediastinal B-cell lymphoma (PMBL) has a high cure rate of 85-95%, with various treatment regimens including RCHOP and DAEPOCH-R; this study examined a protocol involving aggressive immunochemotherapy and intermediate-dose methotrexate.
- The study involved 124 patients, with a median follow-up of 9 years, showing impressive 5-year overall survival (94%) and progression-free survival (92%), influenced by PET-CT results post-chemotherapy.
- The intensive treatment showed low rates of severe side effects (0.8% treatment-related mortality) and late toxicities (2.4% for second malignancies and cardiotoxicity), indicating its effectiveness and safety in young
